The aftermath of Hurricane Helene has led to a severe shortage of IV fluids across the United States, following the damage of a key manufacturing plant. Hospitals are reporting significant impacts, including cancellations of elective surgeries and a reduction in IV fluid administration to emergency room patients. The healthcare sector is struggling to respond, with some institutions resorting to alternative fluids. As the crisis unfolds, the FDA has authorized the extension of expiration dates for certain IV products. Local officials are warning that the shortage may last for months, and patients reliant on IV nutrition are particularly affected. Efforts are underway to restart production at the Baxter plant, but challenges remain as healthcare facilities continue to manage the depletion of supplies.